Gottfried,
Yes, I saw it. Just got in. It was expected, as they said that they were going to do it in the CC, already in the stock price. The most important thing they can do at this point is get a volume production run of SDLT by sometime in the summer, and, then, get backward compatability with DLT within a few months thereafter, as they said in their previous CC. If they can do these things, the stock is dirt cheap here.
Of course, everything is relative--to watch some of these stocks like CREE, GERN, NTAP just to name a couple shooting up like Super Weeds over the past couple of months is just mind boggling. I bought a couple hundred shares of GERN just a couple of months ago as a wild biotech speculation at 15 and change, and have seen it more than triple, boy do I wish I had swapped my DSS stake for it then. I'm not going to get "rich" off it as it is, but, as the saying goes, "Every little bit helps." Being "safe" in this market has meant being "sorry".
Best wishes,
Sam |
